CClinicalTrials.gg
RecruitingNCT04651270Updated Apr 14, 2023

Assessment of the Wide Field of View Provided by the SurroundScope

An interventional study of SurroundScope in Laparoscopic Surgery, sponsored by 270Surgical. Recruiting at 1 site in Israel. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-04-14.

Sponsored by 270Surgical · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Sep 2023, 3 years 1 month ago, but the record still lists the study as recruiting.
  • Started Dec 2020; still recruiting 5 years 9 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
100
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

The aim of this study is to assess the need and potential benefits of the wide field of view during general and gynecology laparoscopic surgery.

Read the detailed description

The tremendous popularity of the laparoscopic surgeries is balanced with its tradeoffs - the needs for an excellent intracavitary visualization along with a surgeon skill set capable of performing these, often more technically challenging procedures. Image quality has improved, but there are still various restrictions to images captured by the lens at the tip of a long tubular laparoscope.

270Surgical developed a 270 degree angle scope to overcome these unmet needs and improve the image quantity and extent during laparoscopy. The study will evaluate standard laparoscopic surgery using the 270Surgical system; "The SurroundScope".

02

Conditions studied

  • Laparoscopic Surgery
03

In context

Lead sponsor

270Surgical is the lead sponsor of 2 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  1. Age greater than or equal to 18
  2. Capable of giving informed consent
  3. Scheduled for general or gynecology laparoscopic surgery or open procedure that in the surgeon's opinion can be performed laparoscopically with the 270System

Exclusion criteria

Exclusion Criteria:

  1. Unfit for surgery: concomitant disorders incompatible with the study or surgery (at the discretion of the investigator)
  2. Patients with contraindications to undergo surgery
  3. Patients with ASA class* >3
  4. Advanced cirrhosis with failure of hepatic function
  5. Patients who have participated in another interventional clinical study in the last month
  6. Pregnancy
  7. Unable to consent (due to cultural, language or neurological barriers)
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
100 participants (estimated)

Study arms

  • Experimental
    SurroundScope

    For laparoscopic camera system, the SurroundScope. 270-degree angle videoscope (270Surgical, Israel) was used

    Device: SurroundScope

Interventions

  • DeviceSurroundScope

    The study will evaluate standard laparoscopic surgery using the 270Surgical system. The procedure will be performed according to the institution's standard of care, using the SurroundScope for visualization.

06

What researchers measure

Primary outcomes

  1. Assessment of the need and potential benefits of the wide field of view

    Assessed by a multi-question subjective questionnaire completed in the OR, immediately after the case, by the surgeon and the camera person and constructed on a Likert-type, 5-point scale (1=Strongly disagree, 2=Disagree, 3=Neither agree or disagree, 4=Agree, 5=Strongly agree).

    Time frame: Day of surgery

Secondary outcomes

  1. Assessment of the 270 Lenses clearance contribution to the procedure.

    Lenses clearance contribution will be assessed by: Rating of the visual impairment due to smoke using a likert-type scale of 1-5: 1=imperceptible, 2= perceptible but not interfering, 3=same as in standard procedure, 4=annoying, 5=Very annoying.

    Time frame: Day of surgery

  2. Assessment of the 270 Lenses clearance contribution to the procedure.

    Lenses clearance contribution will be assessed by: Amount of removals and pauses for fog and smoke incidences using a scale of 1-5: 1=none, 2= less than in standard procedure, 3=same as in standard procedure, 4= more than in standard procedure, 5=much more than in standard procedure.

    Time frame: Day of surgery

  3. A record of complications related to the SurroundScope

    The SurroundScope related operative complications, that require further clinical intervention

    Time frame: Day of surgery up to 2 weeks after the surgical procedure

Other outcomes

  1. Additional measurements - timing, compared to retrospective data of matched anonymous 100 patients' data from the medical records of the hospital.

    Measuring time of laparoscopic procedure (lap inserted to final lap removal)

    Time frame: day of surgery

  2. Additional measurements- Intraoperative events

    Measurements include collecting a log of events that could have been missed with standard scope and were captured in the side screens

    Time frame: day of surgery

  3. Additional measurements - lengs of stay, compared to retrospective data of matched anonymous 100 patients' data from the medical records of the hospital.

    Number of days patients stayed at the hospital following the operation

    Time frame: Up to two weeks

07

Study locations

1 of 1 sites recruiting
  • Bnai Zion Medical Center
    Haifa, 31048, Israel
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 14, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT04651270
Lead sponsor
270Surgical
Responsible party
Sponsor
First posted
Dec 3, 2020
Start date
Dec 9, 2020
Primary completion
Sep 1, 2023 (estimated)
Completion
Dec 30, 2023 (estimated)
Last update
Apr 14, 2023

Study contacts

Gideon Sroka, MD
Contact
Gideon.sroka@b-zion.org.il
+97248359137 ext. 0
Gideon Sroka, MD
principal investigator · Bnai Zion Medical Center, 47 Golomb St. Haifa, 31048, Israel

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion